Real-time CGM for Type 1 diabetes
Type 1 Diabetes (T1D) is an autoimmune disease where the insulin-producing cells of the body are destroyed by the immune system, preventing insulin from being produced. It generally develops in childhood or adolescence but may also develop later in adulthood.
People with Type 1 diabetes need to take insulin to manage their glucose levels. Regularly checking and managing glucose levels is crucial in managing Type 1 diabetes. By using a real-time Continuous Glucose Monitoring system (rt-CGM), one can easily keep track of their glucose levels and predict any changes without the need to prick their finger,* making diabetes management easier and more effective.||,1-4.
The Dexcom ONE+ Continous Glucose Monitoring System is available for purchase.
From 1st January 2022, the Estonian Health Insurance Fund will reimburse the Dexcom ONE Continuous Glucose Monitoring System for people with Type 1 diabetes.
The more effective|| way to manage Type 1 diabetes
See your real-time glucose numbers, at a glance.
Real-time CGM systems automatically transmit glucose readings to your compatible smart device,§ so you’ll always know where your glucose is and where it is headed – without the need to finger prick* or scan. All enabling you to confidently take immediate action when you are heading high or low.
Stay ahead of your hypos day and night
Customisable glucose alerts notify you automatically when your glucose levels are going too high or too low, 24 hours a day. With CGM maintaining a vigilant eye on your glucose levels, you can sleep more peacefully.
Improve your diabetes management together with your healthcare team
Unlike BGM, real-time CGM provides you with valuable insights on your glucose trends and patterns, and helps you track your progress. You can even share your data with your healthcare team to improve your diabetes management.‡
Real-time CGM is proven to drastically improve outcomes
for people with Type 1 diabetes
Reduce Hypoglycemia1,4
Increase time in range†,1,4
Decrease HbA1C1-4
Improve well-being and treatment satisfaction3
The Dexcom difference
Proven accuracy for confident
treatment decisions
Dexcom CGM systems provide accurate5 glucose readings 24/7 even when your glucose levels are rapidly rising or falling.‡‡ Unlike other CGM systems, it does not have any interactions with common substances such as vitamin C or paracetamol.‡‡,6
Customisable alerts you can rely on, 24/7
Dexcom systems offer the widest range of customisable alerts, designed to help you get ahead of your hypos and give you time to take action. Our unique Delay 1st High Alert even allows you to tailor your alerts to your meals and insulin dosing schedule. Our systems also offer unparalleled performance in water† and continue working on a plane, up to 13,000 ft.
Unparalleled flexibility that adapt to your lifestyle
Dexcom CGM systems are suitable for largest age range: age 2 and up and can be worn in multiple locations** – perfect if you want to be discreet, or keep your sensor out of harm’s way. Dexcom CGM systems also connect to a series of health apps for a more connected experience.
Flexible Sensor Placement
The Dexcom sensor is small and discreet and can be worn in multiple locations, giving your you the flexibility to wear it your way.
Upper Buttocks**
Good for small or very young children
Back of upper arm
Easy to reach and great for people who are active.
Abdomen
A discrete option that can be easily covered with clothing.
See how our Dexcom Warriors are leading healthier more
confident lives with better diabetes management
“Dexcom ONE allows me to feel muchsafer and more confident about my diabetes. No matter what I’m doing, even when sleeping, I know it is measuring my glucose levels and it will alert me if I need to make a treatment decision.”
Ioannis, Dexcom Warrior
The featured Warrior is a sponsored spokesperson of Dexcom.
The featured Warrior is a sponsored spokesperson of Dexcom.
"I feel that Dexcom ONE allows me tostay in target range to perform duringmy daily training. Plus, my sensor patchstays on well."
Robert, Dexcom Warrior
The featured Warrior is a sponsored spokesperson of Dexcom.
The featured Warrior is a sponsored spokesperson of Dexcom.
References:
* Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
† The Dexcom ONE+ Sensor is water proof and may be submerged under eight feet of water for up to 24 hours without failure when properly installed.
‡ Discuss with your HCP on how to use CGM information to manage diabetes.
§ For a list of compatible smart devices, please visit www.dexcom.com/compatibility.
|| Compared to BGM.
¶ Study included non-Dexcom CGM.
** Dexcom ONE and Dexcom ONE+ are approved for wear on the arm and abdomen, and ages 2-17 for Dexcom ONE and 2-6 for Dexcom ONE+ can also wear their sensor on the upper buttocks.
†† Time in range was defined as 3.9-10 mmol/L - 70-180 mg/dL.
‡‡ Dexcom ONE and Dexcom ONE+ readings can be used to make diabetes treatment decisions when taking up to a maximum acetaminophen dose of 1,000 mg every six hours.
* Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
† The Dexcom ONE+ Sensor is water proof and may be submerged under eight feet of water for up to 24 hours without failure when properly installed.
‡ Discuss with your HCP on how to use CGM information to manage diabetes.
§ For a list of compatible smart devices, please visit www.dexcom.com/compatibility.
|| Compared to BGM.
¶ Study included non-Dexcom CGM.
** Dexcom ONE and Dexcom ONE+ are approved for wear on the arm and abdomen, and ages 2-17 for Dexcom ONE and 2-6 for Dexcom ONE+ can also wear their sensor on the upper buttocks.
†† Time in range was defined as 3.9-10 mmol/L - 70-180 mg/dL.
‡‡ Dexcom ONE and Dexcom ONE+ readings can be used to make diabetes treatment decisions when taking up to a maximum acetaminophen dose of 1,000 mg every six hours.
1. Beck RW, et al. JAMA 2017;317(4):371-378.
2. Beck RW et al. Ann Intern Med. 2017;167(6):365-374.
3. Lind M et al. JAMA 2017;317(4):379-387.
4. Soupal J et al. Diabetes Care. 2019;43(1):37-43.
5 Haskova et al. Diabetes Care.
6 Shah V et al. Diabetes Technol Ther. 2018;20(6):428-433.
7 Dexcom ONE and Dexcom ONE+ User Guides.
8 Calhoun P et al. J Diabetes Sci Technol. 2018;12(2):393-396.
2. Beck RW et al. Ann Intern Med. 2017;167(6):365-374.
3. Lind M et al. JAMA 2017;317(4):379-387.
4. Soupal J et al. Diabetes Care. 2019;43(1):37-43.
5 Haskova et al. Diabetes Care.
6 Shah V et al. Diabetes Technol Ther. 2018;20(6):428-433.
7 Dexcom ONE and Dexcom ONE+ User Guides.
8 Calhoun P et al. J Diabetes Sci Technol. 2018;12(2):393-396.